Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tolerance of MEDI-522 in patients with advanced solid tumors

Nov. 25, 2003

ANUP peptides reduce tumor growth and inhibit angiogenesis

Nov. 25, 2003

Phase I/II study evaluates Advexin oral rinse for oral premalignancies

Nov. 24, 2003

Novel HDAC inhibitors identified at AstraZeneca

Nov. 24, 2003

New phthalocyanine-based photosensitizers designed by Nihon U. scientists

Nov. 24, 2003

FTY-720 exerts selective antitumor effects on hepatoma cell lines

Nov. 24, 2003

Good tolerability profile for OSI-461 in advanced cancer patients

Nov. 24, 2003

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Oncolytics Biotech

Nov. 24, 2003

Small-molecule HDAC inhibitor JNJ-16241199, a potent, orally active antitumor agent

Nov. 21, 2003

Strong antitumor effects demonstrated for humanized anti-TF monoclonal antibody

Nov. 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...